Every investor is in the markets to find a return, and there are as many investing strategies as there are investors. Some ...

JMP Securities analyst Mitchell Germain maintained a Hold rating on W. P. Carey Inc. (WPC – Research Report) today. The company’s shares closed ...

Fintel reports that on January 9, 2025, JMP Securities downgraded their outlook for Paycor HCM (NasdaqGS:PYCR) from Market ...

JMP Securities analyst Steven Delaney reiterated a Hold rating on Granite Point Mortgage (GPMT – Research Report) today. The company’s shares ...

JMP Securities reissued their market perform rating on shares of Stryker (NYSE:SYK – Free Report) in a research note issued ...

Health Care REITs LTC Properties (LTC) and Sabra Health Care REIT (SBRA) were upgraded at JMP, citing multiple tailwinds are ...

Fintel reports that on January 8, 2025, JMP Securities initiated coverage of Context Therapeutics (NasdaqCM:CNTX) with a ...

JMP Securities has downgraded Alphabet shares (GOOG, GOOGL) to Market Perform from Outperform, citing concerns over pending ...

JMP Securities has recently reduced Uber Technologies Inc (UBER) stock to Mkt Perform rating, as announced on January 2, 2025, according to Finviz. Earlier, on October 31, 2024, Gordon Haskett had ...

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

Context Therapeutics (NASDAQ:CNTX – Get Free Report) was upgraded by Citizens Jmp to a “strong-buy” rating in a note issued ...

JMP Securities has recently raised Sabra Health Care REIT Inc (SBRA) stock to Mkt Outperform rating, as announced on January 7, 2025, according to Finviz. Earlier, on December 5, 2024, Mizuho had ...